Area of research
Cardiology and Cardiovascular Medicine
Research interest
Research interests include Atrial Fibrillation Management and Outcomes, Cardiac Arrhythmias and Treatments, Cardiac pacing and defibrillation studies, and Cardiac electrophysiology and arrhythmias.
Apixaban versus aspirin for stroke prevention in people with subclinical atrial fibrillation and a history of stroke or transient ischaemic attack: subgroup analysis of the ARTESiA randomised controlled trial
Atrial fibrillation and atherosclerosis cause different vascular brain lesions on magnetic resonance imaging
Clinical significance of a new diagnosis of atrial fibrillation in patients with vascular disease
Apixaban vs Aspirin According to CHA2DS2-VASc Score in Subclinical Atrial Fibrillation
Mortality and Morbidity in Adults With Rheumatic Heart Disease
Residual Stroke Risk Among Patients With Atrial Fibrillation Prescribed Oral Anticoagulants: A Patient‐Level Meta‐Analysis From COMBINE AF
Optimizing warfarin dosing for patients with atrial fibrillation using machine learning
Prevalence and Distribution of Intracranial Vessel Occlusion on Angiography and Its Association with Functional Outcome in Patients with Atrial Fibrillation Presenting with Ischemic Stroke
Sodium Intake and Incident Atrial Fibrillation in Individuals With Vascular Disease
Results of the COMPASS Trial Analyzed Using Win Ratio Compared With Conventional Analytic Approaches
Apixaban for Stroke Prevention in Subclinical Atrial Fibrillation
Final Study Report of Andexanet Alfa for Major Bleeding With Factor Xa Inhibitors
Effects of oral anticoagulation in people with atrial fibrillation after spontaneous intracranial haemorrhage (COCROACH): prospective, individual participant data meta-analysis of randomised trials
Outcomes of patients with atrial fibrillation and ischemic stroke while on oral anticoagulation
Colchicine to Prevent Atrial Fibrillation Recurrence After Catheter Ablation: A Randomized, Placebo-Controlled Trial
Outcomes of Patients with a Mechanical Heart Valve and Poor Anticoagulation Control on Warfarin
Individual net clinical outcome with oral anticoagulation in atrial fibrillation using the ABC‐AF risk scores
Plasma angiopoietin-2 and its association with heart failure in patients with atrial fibrillation
Rivaroxaban in Rheumatic Heart Disease–Associated Atrial Fibrillation
Factor XIa inhibition with asundexian after acute non-cardioembolic ischaemic stroke (PACIFIC-Stroke): an international, randomised, double-blind, placebo-controlled, phase 2b trial
Bone morphogenetic protein 10: a novel risk marker of ischaemic stroke in patients with atrial fibrillation
Left Atrial Appendage Occlusion during Cardiac Surgery to Prevent Stroke
Screening for Atrial Fibrillation in the Older Population
Antiplatelet therapy in patients with atrial fibrillation: a systematic review and meta-analysis of randomized trials
Role of Combination Antiplatelet and Anticoagulation Therapy in Diabetes Mellitus and Cardiovascular Disease
Rivaroxaban for Prevention of Covert Brain Infarcts and Cognitive Decline
Full Study Report of Andexanet Alfa for Bleeding Associated with Factor Xa Inhibitors
Safety of Proton Pump Inhibitors Based on a Large, Multi-Year, Randomized Trial of Patients Receiving Rivaroxaban or Aspirin
Recurrent Stroke With Rivaroxaban Compared With Aspirin According to Predictors of Atrial Fibrillation
Pantoprazole to Prevent Gastroduodenal Events in Patients Receiving Rivaroxaban and/or Aspirin in a Randomized, Double-Blind, Placebo-Controlled Trial